bioAffinity Technologies, Inc. (NASDAQ:BIAF, BIAFW)), a biotechnology company focused on the need fo

SAN ANTONIO--(BUSINESS WIRE)---- $BIAF #BIAF--bioAffinity Technologies will effect a 1-for-15 revers

Gainers Tenon Medical (NASDAQ:TNON) stock rose 122.5% to $12.13 during Wednesday's pre-market s

New partner’s national sales force will market CyPath Lung to federal healthcare agencies, including

Gainers Amylyx Pharmaceuticals (NASDAQ:AMLX) stock increased by 27.5% to $27.32 during Tuesday'

SAN ANTONIO--(BUSINESS WIRE)---- $BIAF #AvMEDICAL--bioAffinity Technologies enters distribution agre

JERSEY CITY, N.J., Aug. 14, 2026 /PRNewswire/ -- WallachBeth Capital LLC, a leading provider of capi

SAN ANTONIO--(BUSINESS WIRE)---- $BIAF #BIAF--bioAffinity Technologies announces closing of $4M priv

Gainers Liminatus Pharma (NASDAQ:LIMN) stock increased by 48.4% to $0.16 during Thursday's regu

JERSEY CITY, N.J., , Aug. 13, 2026 /PRNewswire/ -- WallachBeth Capital LLC, a leading provider of ca

SAN ANTONIO--(BUSINESS WIRE)---- $BIAF #BIAF--bioAffinity Technologies announces pricing of $4M priv

bioAffinity Technologies (NASDAQ:BIAF) reported quarterly losses of $(0.64) per share which beat the

SAN ANTONIO, Texas--(BUSINESS WIRE)---- $BIAF #BIAF--bioAffinity Technologies reported second quarte

Titled "Lung Nodules, Lung Microenvironment, Predictive Models and Clinician Risk Stratification

SAN ANTONIO--(BUSINESS WIRE)---- $BIAF #BIAF--BIAF publishes CyPath Lung white paper which presents

bioAffinity and Biodesix pursue different cancer diagnostics strategies, but which oncology stock of

Collaboration increases laboratory throughput and reduces costs for personalized testing for asthma

SAN ANTONIO--(BUSINESS WIRE)---- $BIAF #BIAF--bioAffinity and Pictor partner to advance next-generat

bioAffinity Technologies, Inc. (BIAF) Discusses Innovations in Lung Cancer Screening Technologies fo

bioAffinity's CyPath Lung sales momentum is gaining traction, but wider losses, funding needs and re

BioAffinity Technologies, Inc. (NASDAQ:BIAF, BIAFW)), a biotechnology company focused on the need fo

SAN ANTONIO--(BUSINESS WIRE)---- $BIAF #BIAF--bioAffinity Technology reports continued acceleration

Research suggests a potential topical treatment for common skin cancers, squamous cell and basal cel

SAN ANTONIO--(BUSINESS WIRE)---- $BIAF #BIAF--bioAffinity Technologies reports on preclinical findin

JERSEY CITY, N.J., June 18, 2026 /PRNewswire/ -- WallachBeth Capital LLC, a leading provider of capi

SAN ANTONIO, Texas--(BUSINESS WIRE)-- #BIAF--bioAffinity Technologies announces closing of $3.2 mill

JERSEY CITY, N.J., June 17, 2026 /PRNewswire/ -- WallachBeth Capital LLC, a leading provider of capi

bioAffinity Technologies, Inc. (NASDAQ:BIAF, BIAFW)), a biotechnology company focused on the need fo

SAN ANTONIO--(BUSINESS WIRE)---- $BIAF #BIAF--bioAffinity Technologies announces pricing of a public

bioAffinity Technologies, Inc. (BIAF) Discusses Noninvasive Testing and Risk Stratification for Inde

SAN ANTONIO--(BUSINESS WIRE)---- $BIAF #BIAF--bioAffinity Technologies announces joint webinar with

Upon issuance, the Mexican patent application will protect the use of defined antibodies and the por

bioAffinity Technologies, Inc. (NASDAQ:BIAF, BIAFW)), a biotechnology company focused on noninvasive

bioAffinity Technologies has prioritized CyPath® Lung as its core commercial focus, aligning resourc

bioAffinity Technologies (NASDAQ:BIAF) reported quarterly losses of $(0.81) per share which beat the

Collaboration with nation's largest military medical center focuses on bioAffinity Technologies&

Noninvasive diagnostic continues to gain traction in the current and expanding U.S. addressable mark

bioAffinity Technologies Inc (NASDAQ: BIAF) shares trade higher in Wednesday's premarket after a

BioAffinity stock dips after huge gains. Its CyPath Lung test shows strong results in diagnosing nod